Bifidobacterium breve DSM 32583 and Limosilactobacillus fermentum CECT5716 postbiotics attenuate S. aureus and IL-33-induced Th2 responses

Keyphrases

• Staphylococcus Aureus 100%
• Interleukin-33 (IL-33) 100%
• Th2 Response 100%
• Bifidobacterium Breve 100%
• Postbiotics 100%
• Monocyte-derived Dendritic Cells (MoDCs) 100%
• Lactobacillus Fermentum CECT5716 100%
• Cell-to-cell 60%
• Th2 Cells 60%
• Interleukin-10 40%
• Th1 Response 40%
• In Vitro Study 20%
• Disease Symptoms 20%
• T Cells 20%
• Immune Regulation 20%
• Nave 20%
• Developed Countries 20%
• Strain-induced 20%
• Induced Response 20%
• Human Milk 20%
• Immunomodulatory Effect 20%
• Marker Expression 20%
• Costimulation 20%
• Regulatory Effect 20%
• Allergy 20%
• Cytokine Production 20%
• Anti-inflammatory Cytokines 20%
• T Helper Cells 20%
• HLA-DR 20%
• Allergic Diseases 20%
• CD86 20%
• Type 2 Immune Response 20%
• Compound Probiotics 20%
• CD83 20%
• IL-12p70 20%
• Maturation Markers 20%
• Galacto-oligosaccharides 20%

Immunology and Microbiology

• Dendritic Cell 100%
• Interleukin-33 100%
• Bifidobacterium Breve 100%
• Staphylococcus Aureus 100%
• Th2 Cell 60%
• Interleukin 10 40%
• Inflammatory Cytokine 20%
• Co-Stimulation 20%
• Probiotic 20%
• Immune Response 20%
• Immunity 20%
• Maturation 20%
• Prevalence 20%
• Coculture 20%
• Cytokine Production 20%
• Upregulation 20%
• HLA-DR 20%
• CD86 20%
• CD83 20%
• T Cell 20%